(Q39534489)

12 September 2017

Chemotherapy of localised histiocytic lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A85006

11 November 2022

1 reference

T. P. Miller

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A85006

11 November 2022

S. E. Jones

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A85006

11 November 2022

language of work or name

English

0 references

publication date

1 February 1979

1 reference

12 September 2017

17 February 1979

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=85006

full work available at URL

11 November 2022

https://api.elsevier.com/content/article/PII:S0140673679928940?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(79)92894-0

https://api.elsevier.com/content/article/PII:S0140673679928940?httpAccept=text/plain

11 November 2022

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(79)92894-0

11 November 2022

1 reference

12 September 2017

1

1 reference

12 September 2017

8112

1 reference

12 September 2017

358-360

1 reference

Non-Hodgkin's lymphomas. IV. Clinicopathologic correlation in 405 cases.

12 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992894-0

7 January 2021

Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992894-0

7 January 2021

Non-Hodgkin's lymphomas.V. Results of radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992894-0

7 January 2021

Survival of patients with localized histiocytic lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992894-0

7 January 2021

Recurrence Rates Following Radiation Therapy of Nodular and Diffuse Malignant Lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992894-0

7 January 2021

Advanced diffuse histiocytic lymphoma, a potentially curable disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992894-0

7 January 2021

Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992894-0

7 January 2021

Small cell nonkeratinizing carcinoma of the cervix associated with acth production

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992894-0

7 January 2021

The coexistence of nodular and diffuse patterns in nodular non-Hodgkin's lymphomas.Significance and clinicopathologic correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992894-0

7 January 2021

Non-Hodgkin Lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992894-0

7 January 2021

Combination Chemotherapy in the Treatment of Advanced Hodgkin's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992894-0

7 January 2021

Childhood Hodgkin's disease in Uganda: a ten year experience

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992894-0

7 January 2021

Cancer Treatment Reports

14

61

993

Chabner

1977

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(79)92894-0

11 November 2022

Cancer Treatment Reports

16

61

981

Goffinet

1977

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(79)92894-0

11 November 2022

17

31

1858

Carbone

1971

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(79)92894-0

11 November 2022

Cancer Treatment Reports

18

61

1009

Herman

1977

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(79)92894-0

11 November 2022

Identifiers

1 reference

release_5xsit4fkzjg5vopxyplefuyrty

12 September 2017

0 references

1 reference